| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Jones Jeffrey Alan is a Chief Medical Officer at Cullinan Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | CGEM Cullinan Therapeutics, Inc. | Chief Medical Officer | Sell | 4,632 | $9.67 | $44,791.44 | -2.7% | +31.6% | - | |
| Feb 25, 2025 | CGEM Cullinan Therapeutics, Inc. | Chief Medical Officer | Sell | 4,895 | $8.53 | $41,754.35 | -2.7% | -8.6% | +67.8% | |
| Dec 18, 2024 | CGEM Cullinan Therapeutics, Inc. | Chief Medical Officer | Sell | 4,632 | $11.41 | $52,851.12 | -3.9% | -17.1% | -7.3% | |
| Dec 21, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Medical Officer | Sell | 1,860 | $8.50 | $15,810.00 | -3.2% | +63.8% | +22.4% | |
| Dec 18, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Medical Officer | Sell | 386 | $8.22 | $3,172.92 | -0.7% | +67.8% | +25.8% | |
| Jun 20, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Medical Officer | Sell | 387 | $12.94 | $5,007.78 | -0.7% | -23.1% | +34.0% | |
| May 18, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Medical Officer | Sell | 394 | $8.76 | $3,451.44 | -0.7% | +13.9% | +163.3% | |
| Apr 18, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Medical Officer | Sell | 392 | $10.71 | $4,198.32 | -0.7% | +10.3% | +74.1% | |
| Mar 20, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Medical Officer | Sell | 390 | $11.32 | $4,414.80 | -0.7% | +20.1% | +42.5% |